Scilex Holding SCLX
NASDAQ SCLX
$4.06 -0.34 (-7.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Return on Equity [ROE] (2023)

Updated

Scilex Holding (SCLX) reported Return on Equity [ROE] of -500.49% for Q2 2023, down 310.38 percentage points from the prior quarter.

Analysis

Scilex Holding (SCLX) Return on Equity [ROE] (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.32%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 84.40%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 21.39%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 83.75%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -18.38%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 4.97%
10 Scilex Holding 31.02 Mn 19.00 Mn 3.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -500.49%
Mar 31, 2023 -190.10%
API Access

Scilex Holding Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SCLX&period=max&api_key=YOUR_API_KEY